Valvular & structural heart disease

Natural history of asymptomatic moderate or severe aortic regurgitation: a systematic review and meta-analysis

HeartPublished systematic review and meta-analysis

Authors' conclusion

Asymptomatic moderate/severe AR carries significant excess mortality irrespective of age, contradicting its historically benign reputation. Given the rarity of asymptomatic LV dysfunction, earlier intervention guided by more sensitive markers of LV damage may improve outcomes, although heterogeneity and study quality warrant cautious interpretation.

Study context

Population
Patients with asymptomatic moderate or severe aortic regurgitation (AR)patients in twenty-seven studies, mean age 49 years, mean follow-up 3.9 years
Participants
4,720 patients
Comparison
Hazard ratios (HRs) of AVR vs conservative management
Outcome
Pooled incidence rates of adverse events (per 100 person-years)
Follow-up
Mean 3.9 years
Methodological detailscohort studies, random-effects models for pooled incidence rates, fixed-effects models for hazard ratios
  • Cohort studies
  • Random-effects models for pooled incidence rates
  • Fixed-effects models for hazard ratios

Pooled result

As reported in the abstract

All-cause mortality
1.75 (95% CI 1.27 to 2.41)
Cardiac death
1.29
Sudden death
0.29
New symptoms
4.30
AVR
7.01
Asymptomatic low left ventricular ejection fraction
0.9

Further pooled results

OutcomePooled HR (95% CI)
MortalityEarly AVRvs conservative managementLower mortality with early AVR0.33 (0.30–0.37)

Mortality by cohort mean age (per 100 person-years)

Cohorts with mean age ≥50 years
2.45 (1.90 to 3.18)
Younger cohorts
0.59 (0.29 to 1.21)
Mortality rates more than double those of the general population across age groups

Original publication

Natural history of asymptomatic moderate or severe aortic regurgitation: a systematic review and meta-analysis. Heart. Published 17 November 2025. doi:10.1136/heartjnl-2025-326643

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.